Flavonoids from Vitex trifolia L. inhibit cell cycle progression at G 2/M phase and induce apoptosis in mammalian cancer cells

Journal of Asian Natural Products Research

Volumn 7, Issue 4, 2005, Pages 615-626

  Li, Wen Xin ^a,b   Cui, Cheng Bin ^a,c   Cai, Bing ^a   Wang, Hai Yan ^a   Yao, Xin Sheng ^b,d  

^a Tianjin Institute for Biomedicinal Research   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c OCEAN UNIVERSITY OF CHINA   (China)

^d Traditional Chinese Medicines and Natural Products Research Center Shenzhen   (China)

Author keywords

Anticancer; Apoptosis inducer; Cell cycle inhibitor; Flavonoid; Verbenaceae; Vitex trifolia; Vitexicarpin

Indexed keywords

ANTINEOPLASTIC AGENT; ARTEMETIN; CASTICIN; CELL CYCLE INHIBITOR; CHRYSOSPLENOL D; DNA FRAGMENT; FLAVONOID; LUTEOLIN; PENDULETIN; PERSICOGENIN; PLANT EXTRACT; SULFORHODAMINE B; UNCLASSIFIED DRUG; VITEX TRIFOLIA EXTRACT;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL ASSAY; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CELL STRAIN K 562; CELL STRAIN TSFT210; CELL STRUCTURE; CHINESE MEDICINE; CONTROLLED STUDY; DNA EXTRACTION; DOSE RESPONSE; DRUG EFFECT; DRUG ISOLATION; DRUG STRUCTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; LEUKEMIA CELL; MAMMAL CELL; MASS SPECTROMETRY; MICROSCOPY; MITOSIS INHIBITION; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; TECHNIQUE; ULTRAVIOLET SPECTROSCOPY; VITEX; VITEX TRIFOLIA;

ANIMALS; APOPTOSIS; BIOLOGICAL ASSAY; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL DIVISION; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; FLOW CYTOMETRY; MAMMARY NEOPLASMS, ANIMAL; MICE; NEOPLASMS; VITEX;

MAMMALIA; VERBENACEAE; VITEX TRIFOLIA;

EID: 21344453042     PISSN: 10286020     EISSN: None     Source Type: Journal    
DOI: 10.1080/10286020310001625085     Document Type: Article

References (14)

1. State Pharmacopoeia Commission of China, Pharmacopoeia of P.R.C. pp. 297-298. Chemical Industry Press, Beijing (2000), Part 1.
2. W.-X. Li, C.-B. Cui, B. Cai, X.-S. Yao. J. Asian Nat. Prod. Res., 7, 95-105 (2005).
3. E. Wollenweber, V.H. Dietz, D. Schillo. Z Naturforsch., Teil C, 35, 685-690 (1980).
4. A.S. Chawla, A.K. Sharma, S.S. Handa. Indian J. Chem., 30B, 773-776 (1991).
5. Y. Kondo, K. Sugiyama, S. Nozoe. Chem. Pharm. Bull., 34, 4829-4832 (1986).
6. M. Iinuma, S. Matsuura, K. Kusuda. Chem. Pharm. Bull., 28, 708-716 (1980).
7. X.-Y. Zen, Z.-F. Fang, Y.-Z. Wu, H.-D. Zhang. Chin. J. Mater. Med., 21, 167-168 (1996).
8. S. Philip, S. Ritsa, S. Dominic, S. Dominic, M. Anne. J. Natl Cancer Inst., 82, 1107-1112 (1990).
9. K. Iwashita, M. Kobori, K. Yamaki, T. Tsushida. Biosci. Biotechnol. Biochem., 64, 1813-1820 (2000).
10. Y. Rong, E.B. Yang, K. Zhang, P. Mack. Anticancer Res., 20, 4339-4346 (2000).
11. W.G. Ko, T.H. Kang, S.J. Lee, N.Y. Kim, Y.C. Kim, D.H. Sohn. Food Chem. Toxicol., 38, 861-865 (2000).
12. S.K. Tahir, J.E. Trogadis, J.K. Stevens, A.M. Zimmerman. Biochem. Cell Biol., 70, 1159-1173 (1992).
13. S.K. Tahir, E.K. Han, B. Credo, H.-S. Jae, J.A. Pietenpol, C.D. Scatena. Cancer Res., 61, 5480-5485 (2001).
14. F. Traganos, J. Kapuscinski, J.P. Gong, A. Barbara, R.J. Darzynkiewicz. Z. Darzynkiewicz. Cancer Res., 53, 4613-4618 (1993).